These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3901243)

  • 1. The chemokinetic inhibitory factor (CIF) in serum of CLL patients: correlation with infection propensity and disease activity.
    Siegbahn A; Simonsson B; Venge P
    Scand J Haematol; 1985 Jul; 35(1):80-7. PubMed ID: 3901243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of chemokinetic inhibitory factor (CIF) by normal blood and spleen B lymphocytes.
    Siegbahn A; Rosén A; Venge P; Aman P; Nilsson K
    Leuk Res; 1986; 10(2):179-86. PubMed ID: 3485223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemokinetic inhibitory factor derived from chronic lymphocytic leukaemia cells. Partial purification and characterization of a new lymphokine.
    Siegbahn A; Nilsson K; Venge P
    Scand J Immunol; 1986 Jan; 23(1):15-23. PubMed ID: 3704559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of B-CLL cell-derived chemokinetic inhibitory factor (CIF) to human polymorphonuclear leukocytes.
    Siegbahn A; Garcia RC; Kishi K; Nilsson K; Venge P
    Eur J Haematol; 1987 Aug; 39(2):172-9. PubMed ID: 3666104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a chemokinetic inhibitor in serum from patients with chronic lymphocytic leukaemia.
    Siegbahn A; Venge P; Nilsson K; Simonson B
    Scand J Haematol; 1982 Feb; 28(2):122-31. PubMed ID: 7046030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia.
    Källander CF; Simonsson B; Hagberg H; Gronowitz JS
    Cancer; 1984 Dec; 54(11):2450-5. PubMed ID: 6498737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular origin of the chemokinetic inhibitor of polymorphononuclear leucocytes found in sera from patients with chronic lymphocytic leukaemia.
    Siegbahn A; Venge P; Nilsson K
    Scand J Haematol; 1983 Aug; 31(2):184-92. PubMed ID: 6310732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.
    Rivkina A; Vitols G; Murovska M; Lejniece S
    Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia.
    Molica S; Vitelli G; Levato D; Gandolfo GM; Liso V
    Br J Haematol; 1999 Dec; 107(3):605-10. PubMed ID: 10583266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia.
    Källander CF; Simonsson B; Gronowitz JS; Nilsson K
    Eur J Haematol; 1987 Apr; 38(4):331-7. PubMed ID: 3609253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
    Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
    Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum inhibitory factor for guinea pig macrophage and neutrophil chemotaxis found in cancer patients.
    Miyahara T; Torisu M
    Gan; 1981 Dec; 72(6):854-61. PubMed ID: 7341335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective complement activity in chronic lymphocytic leukemia.
    Heath ME; Cheson BD
    Am J Hematol; 1985 May; 19(1):63-73. PubMed ID: 3845763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
    Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
    J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.
    Hallek M; Emmerich B; Strohmeyer S; Busch R; Reichle A; Senekowitsch R
    Klin Wochenschr; 1988 Aug; 66(16):718-23. PubMed ID: 3172680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.
    Lundin A; Håkansson L; Michaëlsson G; Venge P
    Arch Dermatol Res; 1987; 279(6):385-91. PubMed ID: 3674962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of beta 2-microglobulin by chronic lymphocytic leukaemia cells in vitro.
    Simonsson B; Danersund A; Tötterman TH; Nilsson K; Wibell L
    Scand J Haematol; 1986 May; 36(5):424-9. PubMed ID: 3526529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of thymidine kinase activity in patients with chronic lymphocytic leukemia.
    Stelmach P; Błoński JZ; Wawrzyniak E; Schweiger PE; Wilandt A; Majak PE; Robak T
    Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1321-1330. PubMed ID: 28100842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia.
    Kuhlein E; Laurent G; Rigal F; Delsol G; Pris J; Ducos J
    Clin Exp Immunol; 1982 Feb; 47(2):389-95. PubMed ID: 6978782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.